Synoviolin, protein folding and the maintenance of joint homeostasis

Nature Clinical Practice Rheumatology

Volumn 4, Issue 2, 2008, Pages 91-97

  Yagishita, Naoko ^a   Yamasaki, Satoshi ^a   Nishioka, Kusuki ^a   Nakajima, Toshihiro ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE DEPENDENT PROTEINASE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CYTOKINE; FIBRONECTIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYALURONIC ACID; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 15; INTERLEUKIN 16; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; LEUKEMIA INHIBITORY FACTOR; MACROPHAGE MIGRATION INHIBITION FACTOR; MATRIX METALLOPROTEINASE; PLATELET DERIVED GROWTH FACTOR; PROTEASOME; PROTEIN MDM2; PROTEIN P53; PROTEINASE; SYNOVIOLIN; TRANSFORMING GROWTH FACTOR; TUMOR NECROSIS FACTOR; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE COP1; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CELL CYCLE REGULATION; CELL PROLIFERATION; COLLAGEN DEGRADATION; ENDOPLASMIC RETICULUM; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; RHEUMATOID ARTHRITIS;

APOPTOSIS; ARTHRITIS, RHEUMATOID; EMBRYONIC DEVELOPMENT; ENDOPLASMIC RETICULUM; HOMEOSTASIS; HUMANS; JOINTS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN FOLDING; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-PROTEIN LIGASES;

EID: 38949132564     PISSN: 17458382     EISSN: 17458390     Source Type: Journal    
DOI: 10.1038/ncprheum0699     Document Type: Review

References (51)

1. Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423: 356-361
2. Arend WP (2001) Physiology of cytokine pathways in rheumatoid arthritis. Arthritis Rheum 45: 101-106
3. McInnes IB and Schett G (2007) Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 7: 429-442
4. Stenczyk J et al. (2006) Synovial cell activation. Curr Opin Rheumatol 18: 262-267
5. Huber LC et al. (2006) Synovial fibroblasts: Key players in rheumatoid arthritis. Rheumatology (Oxford) 45: 669-675
6. Knedla A et al. (2007) Developments in the synovial biology field 2006. Arthritis Res Ther 9: 209
7. Spencer-Green G (2000) Etanercept (Enbrel): Update on therapeutic use. Ann Rheum Dis 59 (Suppl 1): I46-49
8. St Clair EW (2002) Infliximab treatment for rheumatic disease: Clinical and radiological efficacy. Ann Rheum Dis 61 (Suppl 2): ii67-69
9. Amano T et al. (2003) Synoviolin, an E3 ubiquitin ligase, as a novel pathogenic factor for arthropathy. Genes Dev 17: 2436-2449
10. Kaneko M et al. (2002) Human HRD1 protects against ER stress-induced apoptosis through ER-associated degradation. FEBS Lett 532: 147-152
11. Nadav E et al. (2003) A novel mammalian endoplasmic reticulum ubiquitin ligase homologous to the yeast Hrd1. Biochem Biophys Res Commun 303: 91-97
12. Kikkert M et al. (2004) Human HRD1 is an E3 ubiquitin ligase involved in degradation of proteins from the endoplasmic reticulum. J Biol Chem 279: 3525-3534
13. Bordallo J et al. (1998) Der3p/Hrd1p is required for endoplasmic reticulum-associated degradation of misfolded lumenal and integral membrane proteins. Mol Biol Cell 9, 209-222
14. Shearer AG and Hampton RY (2004) Structural control of endoplasmic reticulum-associated degradation: Effect of chemical chaperones on 3-hydroxy-3-methylglutaryl-CoA reductase. J Biol Chem 279: 188-196
15. Yagishita N et al. (2005) Essential role of synoviolin in embryogenesis. J Biol Chem 280: 7909-7916
16. Shimaoka Y et al. (1998) Nurse-like cells from bone marrow and synuvium of patients with rheumatoid arthritis promote survival and enhance function of human B cells. J Clin Invest 102: 606-618
17. Tomita T et al. (1999) Establishment of nurse-like stromal cells from bone marrow of patients with rheumatoid arthritis: Indication of characteristic bone marrow microenvironment in patients with rheumatoid arthritis. Rheumatology 38: 854-863
18. Yagishita N et al.: What do synoviolin deficient mice tell us?. In Bone Marrow in RA Patients (Eds Ochi T and Lipsky PE), in press
19. Yamasaki S et al. (2007) Cytoplasmic destruction of p53 by the endoplasmic reticulum-resident ubiquitin ligase 'Synoviolin'. EMBO J 26: 113-122
20. Haupt Y et al. (1997) Mdm2 promotes the rapid degradation of p53. Nature 387: 296-299
21. Kubbutat MH et al. (1997) Regulation of p53 stability by Mdm2. Nature 387: 299-303
22. Leng RP et al. (2003) Pim2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell 112: 779-791
23. Dornan D et al. (2004) The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 429: 86-92
24. Firestein GS et al. (1997) Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci USA 94: 10895-10900
25. Reme T et al. (1998) Mutations of the p53 tumour suppressor gene in erosive rheumatoid synovial tissue. Clin Exp Immunol 111: 353-358
26. Inazuka M et al. (2000) Analysis of p53 tumour suppressor gene somatic mutations in rheumatoid arthritis synovium. Rheumatology 39: 262-266
27. Muller-Ladner U and Nishioka K (2000) p53 in rheumatoid arthritis: friend or foe? Arthritis Res 2: 175-178
28. Sun Y and Cheung HS (2002) p53, proto-oncogene and rheumatoid arthritis. Semin Arthritis Rheum 31: 299-310
29. Yamanishi Y et al. (2002) Regulation of joint destruction and inflammation by p53 in collagen-induced arthritis. Am J Pathol 160: 123-130
30. Simelyte E et al. (2005) Regulation of arthritis by p53: Critical role of adaptive immunity. Arthritis Rheum 59: 1876-1884
31. Ellgaard L et al. (1999) Setting the standards: Quality control in the secretory pathway. Science 286: 1882-1888
32. Schroder M and Kaufman RJ (2005) The mammalian unfolded protein response. Annu Rev Biochem 74: 739-789
33. Rutkowski DT and Kaufman RJ (2004) A trip to the ER: Coping with stress. Trends Cell Biol 14: 20-28
34. Yamasaki S et al. (2005) Rheumatoid arthritis as a hyper-endoplasmic-reticulum-associated degradation disease. Arthritis Res Ther 7: 181-186
35. Yagishita N et al. (2006) Role of Synoviolin in rheumatoid arthritis: Possible clinical relevance. Future Rheumatol 1: 31-36
36. Ritchlin C (2000) Fibroblast biology. Effector signals released by the synovial fibroblast in arthritis. Arthritis Res 2: 356-360
37. Yamasaki S et al. (2006) Resistance to endoplasmic reticulum stress is an acquired cellular characteristic of rheumatoid synovial cells. Int J Mol Med 18: 113-117
38. Zhao L and Ackerman SL (2006) Endoplasmic reticulum stress in health and disease. Curr Opin Cell Biol 18: 444-452
39. Yoshida H (2007) ER stress and diseases. FEBS J 274: 630-658
40. Bence NF et al. (2001) Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292: 1552-1555
41. Hirabayashi M et al. (2001) VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration. Cell Death Differ 8: 977-984
42. Jana NR et al. (2001) Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release. Hum Mol Genet 10: 1049-1059
43. Imai Y et al. (2000) Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J Biol Chem 275: 35661-35664
44. Vabulas RM et al. (2005) Protein synthesis upon acute nutrient restriction relies on proteasome function. Science 23: 1960-1963
45. Yewdell JW (2001) Not such a dismal science: The economics of protein synthesis, folding, degradation and antigen processing. Trends Cell Biol 11: 294-297
46. Hershko A and Ciechanover A (1998) The ubiquitin system. Annu Rev Biochem 67: 426-479
47. Pickart CM (2001) Mechanisms underlying ubiquitination. Annu Rev Biochem 70: 503-533
48. International Human Genome Sequencing Consortium (2004) Finishing the euchromatic sequence of the human genome. Nature 431: 931-945
49. Toh ML et al. (2006) Overexpression of synoviolin in peripheral blood and synoviocytes from rheumatoid arthritis patients and continued elevation in nonresponders to infliximab treatment. Arthritis Rheum 54: 2109-2118
50. Tsuchimochi K et al. (2005) Identification of a crucial site for synoviolin expression. Mol Cell Biol 25: 7344-7356
51. Gao B et al. (2006) The proinflammatory cytokines IL-1 beta and TNF-alpha induce the expression of Synoviolin, an E3 ubiquitin ligase, in mouse synovial fibroblasts via the Erk1/2-ETS1 pathway. Arthritis Res Ther 8: R172